Who needs N.I.H. grants? A lot of red-state universities, for one.

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.

Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t help.

PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.

Plus, a Super Bowl three-peat?

R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the immune response.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.

Vivek Ramaswamy, Elon Musk’s partner in an effort to cut government costs, could make decisions that ultimately make him and his investors richer.

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.

Consumer and food safety groups have long urged the agency to revoke the use of this dye and others. The F.D.A. says there still is no evidence it is a human carcinogenic.

Scientists have identified a gene that causes production of a substance in some citrus that interferes with many medications.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

Venomous snakes bite millions of people worldwide each year, killing at least 120,000. Many of them are poor people in rural areas of Africa without easy access to treatment.

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.

Even quaint corners of the country are seeing a rise in drug violence and crime. Just ask the mayor of Morlaix, which has a population of about 15,000.

Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.